Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRKR Marker Therapeutics, Inc.

交易中 12-23 11:40:35 EST

3.42

-0.38

-10.06%

最高3.95	最低3.27	成交量3.22万
今开3.85	昨收3.80	日振幅17.86%
总市值3,050万	流通市值2,312万	总股本892.35万
成交额11.24万	换手率0.48%	流通股本676.36万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRKR","market":"US","secType":"STK","nameCN":"Marker Therapeutics, Inc.","latestPrice":3.4177,"timestamp":1734971879734,"preClose":3.8,"halted":0,"volume":32196,"delay":0,"floatShares":6763610,"shares":8923490,"eps":-1.088484,"marketStatus":"交易中","marketStatusCode":2,"change":-0.3823,"latestTime":"12-23 11:40:35 EST","open":3.85,"high":3.95,"low":3.2712,"amount":112419.70044480001,"amplitude":0.178632,"askPrice":3.52,"askSize":28,"bidPrice":3.39,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.088484,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"adjPreClose":3.8,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.65,"preClose":3.8,"latestTime":"09:01 EST","volume":109,"amount":397.84999999999997,"timestamp":1734962465992},"postHourTrading":{"tag":"盘后","latestPrice":3.8,"preClose":3.8,"latestTime":"16:00 EST","volume":105,"amount":399,"timestamp":1734728402770},"volumeRatio":0.528055,"impliedVol":5.7071,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/MRKR","defaultTab":"news","newsList":[{"id":"2492107797","title":"BUZZ--美国股票走势-达顿餐厅、Natgas 公司、Affirm 控股公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492107797","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492107797?lang=zh_cn&edition=full","pubTime":"2024-12-20 02:42","pubTimestamp":1734633724,"startTime":"0","endTime":"0","summary":"美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.59%，报42574.63点；标普500指数.SPX上涨0.50%，报5901.62点；纳斯达克综合指数.IXIC上涨0.49%，报19486.76点。nL4N3NK1B5  ** Tapestry TPR.N：BUZZ--在杰富瑞将评级上调至 \"买入\"、PT上调至街市高位后上涨 nL4N3NK0Y0X ** Peloton Interactive PTON.O:BUZZ - 股价上涨；Telsey Advisory Group上调PT评级 nL4N3NH0X8  ** 埃森哲ACN.N:BUZZ - 上调25财年收入预期后股价上涨 nL4N3NK1AQ  ** Oklo OKLO.N:BUZZ - 在Wedbush将其评级定为 \"跑赢大盘 \"后股价上涨 nL4N3NK10D  ** Okta OKTA.O:BUZZ - 因KeyBanc将其评级上调至 \"增持 \"而上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4S3NK1JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBR","VNCE","MRKR","LW","ALT","BK4208","WGO","VRTX","OKTA","USB","AFRM","CNX","GEV","CAG","DRI","WBD","NEXT","CTAS","TPET","AMAT","LU0289961442.SGD","LYV","CMCSA","EQT","ZM","SHCO","ACN","PAYX","SRE","TPR","LU2362541513.USD","PBM","EWCZ","MU","PTON","RTX","KMX"],"gpt_icon":1},{"id":"2492170160","title":"BUZZ--美国股票走势-Paychex、RTX、波音公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2492170160","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492170160?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:50","pubTimestamp":1734623434,"startTime":"0","endTime":"0","summary":".N美东时间10:30，道琼斯工业平均指数.DJI上涨0.33%，报42465.99点。标普500指数.SPX上涨0.34%，报5892.37点；纳斯达克综合指数.IXIC上涨0.30%，报19451.09点。nL4N3NK10M  ** CarMax KMX.N：BUZZ--该公司公布两年多来首次季度销售额增长后上涨。nL4N3NK141  ** Conagra Brands CAG.N:BUZZ - 在下调年度利润预期后下跌 nL4N3NK0ZT  ** Zoom Communications ZM.O:BUZZ - 因杰富瑞看好人工智能货币化计划而上涨 nL6N3NK0H3  ** Marker Therapeutics MRKR.O:BUZZ - 1600万美元私募后下滑 nL4N3NK15T  ** C3.ai AI.N:BUZZ - 因KeyBanc将其评级下调至 \"减持 \"而下跌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK1F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACN","IE00BFTCPJ56.SGD","BPTH","IE00B3S45H60.SGD","LU0661504455.SGD","TPR","LU1571399168.USD","TPET","BA","LU0823417737.USD","RTX","PRFX","VRTX","USB","DRI","WGO","OKTA","ZM","LW","BK4560","EPAM","LU2360106780.USD","APCX","LU1228905540.USD","IE00B19Z3B42.SGD","BK4130","BK4528","PTON","LU0950375773.USD","CAG","MU","ALT","BK4141","MRKR","PAYX","CTAS","SHCO","SOC","KMX","KBR"],"gpt_icon":1},{"id":"2492469171","title":"Marker Therapeutics, Inc.盘中异动 股价大跌5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492469171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492469171?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:31","pubTimestamp":1734618665,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时31分，Marker Therapeutics, Inc.股票出现波动，股价急速下跌5.71%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.72%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223105984cd90b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223105984cd90b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2492176536","title":"BUZZ--美国股票走势-Oklo、Okta、Zoom","url":"https://stock-news.laohu8.com/highlight/detail?id=2492176536","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492176536?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:14","pubTimestamp":1734617668,"startTime":"0","endTime":"0","summary":"** 意法半导体STM.N：BUZZ - 欧洲芯片股在美光发布不乐观的季度指引后下跌 nL8N3NK0CO 。nL4N3NK0X5  ** Tapestry TPR.N：BUZZ--在杰富瑞将评级上调至 \"买入\"、PT上调至街市高位后上涨 nL4N3NK0Y0X ** Peloton Interactive PTON.O:BUZZ - 股价上涨；Telsey Advisory Group上调PT评级 nL4N3NH0X8  ** 埃森哲ACN.N:BUZZ - 上调25财年收入预期后股价上涨 nL4N3NK0XM  ** Oklo OKLO.N:BUZZ - 在Wedbush将其评级定为 \"跑赢大盘 \"后股价上涨 nL4N3NK10D  ** Okta OKTA.O:BUZZ - 因KeyBanc将其评级上调至 \"增持 \"而上涨。nL4N3NK10M  ** CarMax KMX.N：BUZZZ--该公司两年多来首次实现季度销售额增长，股价上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4S3NK18H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU2417539215.USD","ZM","CAG","LU0056508442.USD","LU0175139822.USD","LU1571399168.USD","LU2048586759.USD","LU0511384066.AUD","LU0061475181.USD","BK4505","IE00BFTCPJ56.SGD","PTON","BK4566","LU0127658192.USD","IE00B19Z9P08.USD","ACN","LU2250418816.HKD","OKLO","BK4528","VRTX","IE0002141913.USD","LU2286300806.USD","LU0157215616.USD","LW","LU2456880835.USD","KMX","LU1878469433.USD","LU2211815571.USD","LU0289739699.SGD","LU1989772923.USD","LU1035775433.USD","LU0719512351.SGD","MU","OKTA","BK4585","SG9999018857.SGD","BK4599","LU1093756325.SGD","LU1366333091.USD","LU0323240290.USD","SG9999014898.SGD","AI","ALT","IE00B19Z3581.USD","BK4532","MRKR","TPR","LU0109394709.USD","BK4516"],"gpt_icon":1},{"id":"2492200931","title":"BUZZ-Marker Therapeutics 在完成 1,600 万美元私募后业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2492200931","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492200931?lang=zh_cn&edition=full","pubTime":"2024-12-19 21:29","pubTimestamp":1734614989,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    12月19日 - ** 药物开发商 Marker Therapeutics    股价盘前下跌 25.5% 至 3 美元** MRKR宣布 (link) 1610万美元私募融资** 此次融资所得款项将用于支持 MT-601 的临床开发，MT-601 是一种基于下一代 T 细胞的疗法，用于治疗复发淋巴瘤患者 - MRKR** 投资者支付的购买价为 3.20 美元/每股，认股权证的行权价为 4.03 美元/每股** 截至上次收盘，该公司股价已累计下跌 26.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2491375838","title":"Marker Therapeutics, Inc.盘中异动 股价大跌6.36%报4.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491375838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491375838?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:31","pubTimestamp":1734100265,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时31分，Marker Therapeutics, Inc.股票出现波动，股价快速下跌6.36%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223105984bd668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223105984bd668&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2490768041","title":"Marker Therapeutics, Inc.盘中异动 股价大涨5.40%报4.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490768041","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490768041?lang=zh_cn&edition=full","pubTime":"2024-12-11 01:52","pubTimestamp":1733853129,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日01时52分，Marker Therapeutics, Inc.股票出现异动，股价大幅拉升5.40%。截至发稿，该股报4.10美元/股，成交量1.4576万股，换手率0.16%，振幅9.25%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121101520995e8b7ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121101520995e8b7ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2489231719","title":"Marker Therapeutics, Inc.盘中异动 股价大涨6.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489231719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489231719?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:34","pubTimestamp":1733495675,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时34分，Marker Therapeutics, Inc.股票出现异动，股价快速拉升6.68%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223435a1d970c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223435a1d970c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2488608149","title":"Marker Therapeutics, Inc.盘中异动 快速下挫5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488608149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488608149?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:35","pubTimestamp":1733153730,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时35分，Marker Therapeutics, Inc.股票出现波动，股价大幅跳水5.14%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202233530abf022a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202233530abf022a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2486835194","title":"Marker Therapeutics, Inc.盘中异动 下午盘股价大跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486835194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486835194?lang=zh_cn&edition=full","pubTime":"2024-11-27 03:35","pubTimestamp":1732649714,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日03时35分，Marker Therapeutics, Inc.股票出现波动，股价大幅跳水5.59%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127033514a257c5fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127033514a257c5fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ","BK4139"],"gpt_icon":0},{"id":"2485200915","title":"Marker Therapeutics, Inc.2024财年第三财季实现净利润-2.31百万美元，同比增加22.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485200915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485200915?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377615,"startTime":"0","endTime":"0","summary":"11月24日，Marker Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.31百万美元，同比增加22.48%；其中营业收入为1.93百万美元，同比增加649.21%，每股基本收益为-0.26美元。从资产负债表来看，Marker Therapeutics, Inc.总负债3.46百万美元，其中短期债务0.00美元，资产负债比为3.16，流动比率为3.16。机构评级：截至2024年11月24日，当前有1家机构对Marker Therapeutics, Inc.目标价做出预测，其中目标均价为19.00美元，其中最低目标价为19.00美元，最高目标价为19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000022abd9b87b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000022abd9b87b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","LENZ"],"gpt_icon":0},{"id":"2485143892","title":"Marker Therapeutics, Inc.盘中异动 临近收盘快速上涨9.09%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485143892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485143892?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:59","pubTimestamp":1732309185,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时59分，Marker Therapeutics, Inc.股票出现异动，股价大幅上涨9.09%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123045945971a82c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123045945971a82c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2484692806","title":"Marker Therapeutics, Inc.盘中异动 股价大涨6.14%报3.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484692806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484692806?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:35","pubTimestamp":1732026939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时35分，Marker Therapeutics, Inc.股票出现波动，股价急速上涨6.14%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223539971a76c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223539971a76c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2484777456","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484777456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484777456?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:51","pubTimestamp":1731945099,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时51分，Marker Therapeutics, Inc.股票出现波动，股价急速上涨5.86%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235139abccd029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235139abccd029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2479039020","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479039020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479039020?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:38","pubTimestamp":1730385507,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时38分，Marker Therapeutics, Inc.股票出现波动，股价急速拉升5.65%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.36%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031223828a2026bd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031223828a2026bd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2477371006","title":"Marker Therapeutics, Inc.盘中异动 股价大跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477371006","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477371006?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:17","pubTimestamp":1729779437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时17分，Marker Therapeutics, Inc.股票出现波动，股价大幅下跌6.34%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024221717a1e748f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024221717a1e748f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2477952778","title":"Marker Therapeutics, Inc.盘中异动 股价大涨5.68%报3.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477952778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477952778?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:35","pubTimestamp":1729528510,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时35分，Marker Therapeutics, Inc.股票出现波动，股价快速拉升5.68%。截至发稿，该股报3.72美元/股，成交量7854股，换手率0.09%，振幅6.08%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200351098e3d956&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200351098e3d956&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRKR","BK4139","LENZ"],"gpt_icon":0},{"id":"2475992482","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大涨6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475992482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475992482?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:31","pubTimestamp":1729085491,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时31分，Marker Therapeutics, Inc.股票出现波动，股价快速拉升6.42%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410162131319f47d1bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410162131319f47d1bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MRKR","LENZ"],"gpt_icon":0},{"id":"2475268501","title":"Marker Therapeutics, Inc.盘中异动 早盘股价大跌5.31%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475268501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475268501?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:38","pubTimestamp":1728999516,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时38分，Marker Therapeutics, Inc.股票出现异动，股价急速下跌5.31%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213836971a05f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213836971a05f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0},{"id":"2472957963","title":"Marker Therapeutics, Inc.盘中异动 早盘大幅拉升10.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472957963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472957963?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:34","pubTimestamp":1728048875,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时34分，Marker Therapeutics, Inc.股票出现波动，股价急速拉升10.42%。Marker Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Marker Therapeutics, Inc.公司简介：Marker Therapeutics Inc 是一家临床阶段的免疫肿瘤公司，专门从事新型 T 细胞免疫疗法和创新肽疫苗的开发和商业化，用于治疗血液恶性肿瘤和实体瘤适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421343698e3a955&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421343698e3a955&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","MRKR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.markertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0663},{"period":"1month","weight":0.195},{"period":"3month","weight":0.2925},{"period":"6month","weight":-0.1204},{"period":"1year","weight":-0.0476},{"period":"ytd","weight":-0.3091}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marker Therapeutics, Inc.是一家临床阶段的免疫肿瘤学公司，专门开发下一代T细胞免疫疗法，用于治疗血液系统恶性肿瘤和实体肿瘤适应症。 Marker的细胞治疗技术基于非工程化的肿瘤特异性T细胞的选择性扩增，其识别肿瘤相关抗原（即肿瘤靶标）并杀死表达这些靶标的肿瘤细胞。一旦输入患者，这组T细胞攻击多个肿瘤靶标并起到激活患者免疫系统的作用，以产生广谱抗肿瘤活性。由于Marker不对其T细胞进行基因工程改造，因此与目前基于CAR-T和TCR的工程方法相比，其产品（i）的成本更低，更容易制造，（ii）毒性明显降低，（ iii）与有意义的临床益处相关。因此，与当前基因修饰的CAR-T和基于TCR的疗法相比，Marker认为其T细胞疗法组合具有引人注目的治疗产品特征。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.027161},{"month":2,"riseRate":0.375,"avgChangeRate":-0.06492},{"month":3,"riseRate":0.5,"avgChangeRate":-0.065853},{"month":4,"riseRate":0.375,"avgChangeRate":0.001238},{"month":5,"riseRate":0.5,"avgChangeRate":0.232573},{"month":6,"riseRate":0.625,"avgChangeRate":0.292775},{"month":7,"riseRate":0.125,"avgChangeRate":-0.07757},{"month":8,"riseRate":0.375,"avgChangeRate":0.002117},{"month":9,"riseRate":0.25,"avgChangeRate":-0.071254},{"month":10,"riseRate":0.375,"avgChangeRate":-0.038018},{"month":11,"riseRate":0.25,"avgChangeRate":-0.08549},{"month":12,"riseRate":0.333333,"avgChangeRate":0.059565}],"exchange":"NASDAQ","name":"Marker Therapeutics, Inc.","nameEN":"Marker Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marker Therapeutics, Inc.,MRKR,Marker Therapeutics, Inc.股票,Marker Therapeutics, Inc.股票老虎,Marker Therapeutics, Inc.股票老虎国际,Marker Therapeutics, Inc.行情,Marker Therapeutics, Inc.股票行情,Marker Therapeutics, Inc.股价,Marker Therapeutics, Inc.股市,Marker Therapeutics, Inc.股票价格,Marker Therapeutics, Inc.股票交易,Marker Therapeutics, Inc.股票购买,Marker Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marker Therapeutics, Inc.(MRKR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marker Therapeutics, Inc.(MRKR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况